Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
Article has an altmetric score of 3

See more details

Referenced in 3 patents
25 readers on Mendeley
  • Article usage
  • Citations to this article (110)

Advertisement

Research Article Free access | 10.1172/JCI2312

Exacerbation of antigen-induced arthritis in urokinase-deficient mice.

N Busso, V Péclat, K Van Ness, E Kolodziesczyk, J Degen, T Bugge, and A So

Centre Hospitalier Universitaire Vaudois, Laboratoire de Rhumatologie, 1011 Lausanne, Switzerland. Nathalie.Busso@chuv.hospvd.ch

Find articles by Busso, N. in: JCI | PubMed | Google Scholar

Centre Hospitalier Universitaire Vaudois, Laboratoire de Rhumatologie, 1011 Lausanne, Switzerland. Nathalie.Busso@chuv.hospvd.ch

Find articles by Péclat, V. in: JCI | PubMed | Google Scholar

Centre Hospitalier Universitaire Vaudois, Laboratoire de Rhumatologie, 1011 Lausanne, Switzerland. Nathalie.Busso@chuv.hospvd.ch

Find articles by Van Ness, K. in: JCI | PubMed | Google Scholar

Centre Hospitalier Universitaire Vaudois, Laboratoire de Rhumatologie, 1011 Lausanne, Switzerland. Nathalie.Busso@chuv.hospvd.ch

Find articles by Kolodziesczyk, E. in: JCI | PubMed | Google Scholar

Centre Hospitalier Universitaire Vaudois, Laboratoire de Rhumatologie, 1011 Lausanne, Switzerland. Nathalie.Busso@chuv.hospvd.ch

Find articles by Degen, J. in: JCI | PubMed | Google Scholar

Centre Hospitalier Universitaire Vaudois, Laboratoire de Rhumatologie, 1011 Lausanne, Switzerland. Nathalie.Busso@chuv.hospvd.ch

Find articles by Bugge, T. in: JCI | PubMed | Google Scholar

Centre Hospitalier Universitaire Vaudois, Laboratoire de Rhumatologie, 1011 Lausanne, Switzerland. Nathalie.Busso@chuv.hospvd.ch

Find articles by So, A. in: JCI | PubMed | Google Scholar

Published July 1, 1998 - More info

Published in Volume 102, Issue 1 on July 1, 1998
J Clin Invest. 1998;102(1):41–50. https://doi.org/10.1172/JCI2312.
© 1998 The American Society for Clinical Investigation
Published July 1, 1998 - Version history
View PDF
Abstract

In rheumatoid arthritis, synovial expression of urokinase (uPA) activity is greatly increased (Busso, N., V. Péclat, A. So, and A. -P. Sappino. 1997. Ann. Rheum. Dis. 56:550- 557). We report the same effect in murine antigen-induced arthritis. uPA-mediated plasminogen activation in arthritic joints may have deleterious effects via degradation of cartilage and bone matrix proteins as well as beneficial effects via fibrin degradation. We evaluated these contrasting effects in vivo by analyzing the phenotype of uPA-deficient (uPA-/-) and control mice during antigen-induced arthritis. Joint inflammation was comparable in both groups up to day 3 and subsequently declined in control mice, remaining significantly elevated in uPA-/- mice on days 10 and 30 after arthritis onset. Likewise, synovial thickness was markedly increased in uPA-deficient mice persisting for up to 2 mo, whereas it subsided in control animals. Bone erosion was exacerbated in uPA-/- mice on day 30. By contrast, no difference in articular cartilage proteoglycan content was found between both groups. Significantly increased accumulation of fibrin was observed by day 30 in arthritic joints of uPA-/- mice. We hypothesized that synovial fibrin deposition plays a role in joint inflammation. Accordingly, defibrinogenation of uPA-/- mice by ancrod significantly decreased the sustained joint inflammation. All the above observations were reproducible in plasminogen-deficient (Pln-/-) mice. In conclusion, synovial fibrin deposition plays a role as a nonimmunological mechanism which sustains chronic arthritis.

Version history
  • Version 1 (July 1, 1998): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

Article has an altmetric score of 3
  • Article usage
  • Citations to this article (110)

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 3 patents
25 readers on Mendeley
See more details